Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family.

The extracellular domain of the PRL receptor (PRL-R) is composed of two subdomains of approximately 100 amino acids, S1 and S2. To explore the functional significance of these subdomains in PRL binding and signal transduction, deletion mutants of S1 or/and S2 subdomains were constructed. We report here the inability of each of these mutant receptor forms to bind PRL after expression in COS-7 cells. We also studied the abilities of these different mutant receptors to respond to hormonal stimulation after transfection of each mutant complementary DNA into CHO-K1 cells along with a chimeric gene containing the promoter of a milk protein gene (beta-lactoglobulin) fused to chloramphenicol acetyltransferase coding sequence. Somewhat unexpectedly, a constitutively (PRL-independent) mutant form of the PRL-R was obtained after deletion of the S2 subdomain. Moreover, we analyzed, in CHO-K1 cells, the biological activity of chimeric receptors constructs in which each subdomain sequence was replaced by an unrelated, but coding, sequence of foreign protein, and we confirmed a specific requirement for the S1 sequence in the constitutive activity. In contrast, the S2 subdomain produced an inhibitory effect on S1 constitutive activity. Cotransfection experiments with the wild-type receptor and the constitutive mutant receptor provided evidence that the wild-type receptor was able to inhibit the constitutive activity of the deleted mutant. Furthermore, in the mouse mammary epithelial cell line HC11, the constitutive PRL-R form was able to induce transcription of the beta-casein gene in the absence of PRL. These results suggest a complex signal transduction process that implicates each extracellular PRL-R subdomain. Possible mechanisms for the constitutive effect are discussed.

[1]  M. Ultsch,et al.  The X-ray structure of a growth hormone–prolactin receptor complex , 1994, Nature.

[2]  G. Devauchelle,et al.  Evidence for N‐glycosylation and ubiquitination of the prolactin receptor expressed in a baculovirus‐insect cell system , 1994, FEBS letters.

[3]  P. Kelly,et al.  Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Lodish,et al.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization , 1994, Molecular and cellular biology.

[5]  W. Farrar,et al.  Activation of receptor-associated tyrosine kinase JAK2 by prolactin. , 1994, The Journal of biological chemistry.

[6]  P. Kelly,et al.  Roles of extracellular and cytoplasmic domains of the prolactin receptor in signal transduction to milk protein genes. , 1993, Molecular endocrinology.

[7]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[8]  O. Silvennoinen,et al.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.

[9]  K. Yasukawa,et al.  Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130. , 1993, The EMBO journal.

[10]  W. Wood,et al.  Mechanism-based design of prolactin receptor antagonists. , 1993, The Journal of biological chemistry.

[11]  J. Mornon,et al.  Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Kelly,et al.  Identification of ligand binding determinants of the prolactin receptor. , 1992, The Journal of biological chemistry.

[13]  H. Lodish,et al.  Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[15]  A. Wilks,et al.  Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase , 1991, Molecular and cellular biology.

[16]  H. Lodish,et al.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.

[17]  P. Kelly,et al.  Prolactin stimulates milk protein promoter in CHO cells cotransfected with prolactin receptor cDNA , 1990, Molecular and Cellular Endocrinology.

[18]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.

[19]  J. Garnier,et al.  Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain. , 1989, Science.

[20]  M. Mahmoudi,et al.  Comparison of two different hybridization systems in northern transfer analysis. , 1989, BioTechniques.

[21]  B. Groner,et al.  Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Groner,et al.  Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line. , 1988, The EMBO journal.

[23]  P. Kelly,et al.  Immunological recognition of the prolactin receptor: identification of a single binding unit of molecular weight ≈42 000 , 1987 .

[24]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[25]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[26]  M. Yaniv,et al.  Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma , 1984, Cell.

[27]  I. Pastan,et al.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.